Skip to main content
Glama

Ecfr

by io.github.pipeworx-io

Resolve Entity

resolve_entity
Read-onlyIdempotent

"What's the ticker for…" / "find the CIK for…" / "what's the LEI for…" / "what's the RxCUI for…" / "look up the ID for…" / "what is X's official identifier" / "who owns X" / "is X a subsidiary of Y" — resolve a user-spoken NAME to the canonical/official identifiers other tools require as input. Use FIRST whenever you have a name but need an ID. SUPPORTED TYPES: "company" (cross-source identity spine: 10-digit CIK + ticker + company_name from SEC EDGAR, legal-entity LEI from GLEIF with parent/ultimate-parent/children ownership when the LEI resolves, and security FIGI from OpenFIGI — by exact ticker map when a ticker is implied, and otherwise by name search, so NON-EQUITY instruments that never have a ticker (municipal and corporate bonds, notes, authority debt) DO resolve here; when a name matches more than one instrument it asserts nothing and returns figi_candidates to pick from, which is the correct answer to an issuer name that does not identify a single bond; every identifier is labelled with the source that established it, and an identifier that could NOT be resolved is stated explicitly under unresolved rather than omitted — accepts ticker, CIK, ISIN, or company name as input; an ISIN like "CH0038863350" resolves to the LEGAL ENTITY that issued the security via the GLEIF ISIN-to-LEI mapping, covering non-US issuers EDGAR cannot reach), "drug" (returns RxCUI + ingredient + brand from RxNorm + pipeworx://rxnorm/concept/{rxcui} citation; accepts brand or generic name). LEI/FIGI enrichment degrades gracefully — if GLEIF or OpenFIGI is unavailable, the EDGAR identifiers still return. Each call cascades through several lookup endpoints internally — using resolve_entity replaces 2-3 manual lookups.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYesEntity type: "company" or "drug".
valueYesFor company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., "ozempic", "metformin"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed ("NEW YORK ST DORM AUTH"), never the question's full noun phrase ("NEW YORK ST DORM AUTH revenue bonds"): the FIGI lookup matches instrument names, so trailing security-class words match nothing.

Schema Changelog

Changes observed during successful MCP inspections. Dates show when Glama detected each change.

  1. Changed1 schema field changed
    • changedInput schema / properties / value / description
      Previous value: -"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\")."New value: +"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed (\"NEW YORK ST DORM AUTH\"), never the question's full noun phrase (\"NEW YORK ST DORM AUTH revenue bonds\"): the FIGI lookup matches instrument names, so trailing security-class words match nothing."
  2. First observed

TDQS

A4.8/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already indicate read-only, open-world, idempotent, and non-destructive behavior. The description adds valuable behavioral context: graceful degradation when LEI/FIGI enrichment is unavailable, explicit `unresolved` reporting, and returning `figi_candidates` rather than guessing on ambiguous matches.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness5/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is long but front-loaded with trigger phrases and the core purpose before diving into type-specific details. Every sentence adds operational value, and the structure mirrors decision flow: when to use, what it returns, then edge cases.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

With no output schema, the description carries the return-value burden and meets it: it states returned identifiers (CIK, ticker, LEI, FIGI, RxCUI), labels sources, explains ambiguous-result behavior, and covers failure modes. The detail level is appropriate for a tool with two entity types and cascading lookups.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters5/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Although schema coverage is 100%, the description adds substantial meaning beyond the schema: it explains accepted formats for `value` (ticker, CIK, ISIN, name), provides explicit warnings about bond issuer names, and enumerates what each `type` resolves to. This prevents common invocation errors.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description defines a clear, specific action: resolving a user-spoken name to canonical/official identifiers. It lists supported entity types and gives concrete trigger phrases, distinguishing resolve_entity as the identity-lookup step before other tools.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines4/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

The description explicitly states 'Use FIRST whenever you have a name but need an ID,' giving clear when-to-use guidance. It does not name sibling tools or articulate when-not-to-use alternatives, but the role and supported types are clear enough for an agent to route correctly.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

All Ecfr toolsInspect
Try in Browser
RayrunBuild, deploy, and operate MCP servers without becoming an infrastructure team.ray.runAd

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A3.7/5.0
Disambiguation2/5

Multiple tools have heavily overlapping purposes: ask_pipeworx, ask_pipeworx_beta, and ask_pipeworx_grounded are near-duplicates (beta is currently identical), and ai_visibility_check vs scan_competitor_ai_presence plus deep_research vs ask_pipeworx create real selection ambiguity. Some clusters like the memory trio and CFR read tools are distinct, but the overall set is confusing.

Naming Consistency3/5

Most tools use snake_case and many follow a verb_noun pattern (search_regulations, generate_llms_txt, validate_claim), but noun-first names (entity_profile, title_structure, ai_visibility_check) and prefix families (polymarket_*, pipeworx_*) break the pattern. The conventions are mixed but still readable and mostly predictable.

Tool Count2/5

35 tools is heavy for any single server, and the bulk of them (Polymarket betting, memory, AI visibility, npm scanning, subscriptions) are unrelated to the server's 'Ecfr' name, which suggests a narrow regulatory focus. This is a kitchen-sink scope, making the count feel bloated rather than well-scoped.

Completeness3/5

The eCFR-specific surface is thin — list_titles, search_regulations, get_section_text, and title_structure cover basic read/search but lack version history, update tracking, or agency-level navigation. Other mini-domains (data lookup, polymarket, subscriptions, memory) are individually fairly complete, but the absence of a unified purpose leaves clear gaps overall.

Resources